INTRODUCTION
Apoptosis is a major form of cell death important for the control of cell populations during normal development and in certain diseases [1, 2] . Various aspects of the apoptotic process are conserved between the nematode and man. In Caenorhabditis elegans two genes, ced-3 and ced-4, are critical for cell death [3, 4] . Ced-3 encodes a protein related to mammalian interleukin-1β converting enzyme (ICE) [3, 4] , a member of a new class of cysteine proteases with a marked specificity for aspartic acid in the P " position [5, 6] . Currently there are seven known members of this family : ICE, prICE\CPP32\Yama\apopain, ICE rel II\ Tx\Ich-2, ICE rel -III, Ich-1\Nedd 2, Mch-2 and Mch-3 [3, 5, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Overexpression of these proteases results in apoptosis [7, [10] [11] [12] [13] [14] [15] . Studies with ICE knockout mice suggest that ICE itself is not apparently required for apoptosis except in Fasinduced apoptosis in thymocytes [18, 19] . These results suggest that either there is redundancy amongst the proteases or that an ICE homologue(s) other than ICE is of critical importance in apoptosis [20] . These proteases are synthesized as inactive precursors requiring cleavage at specific Asp residues to two subunits of approximate molecular masses 20 and 10 kDa, which together form the active enzyme [5, 6] . As the cleavage occurs at Asp residues, it suggests that these proteases may autoprocess, or alternatively that some ICE-like proteases may activate other family members [6, 7, 9] .
Apoptosis is characterized by a series of distinctive morphological and biochemical changes. For example the chromatin condenses and is cleaved initially into large kilobase pair fragments (200-300 and 30-50 kb pairs) followed by internucleosomal fragmentation [1, [21] [22] [23] . Proteolysis of poly(ADPribose) polymerase (PARP), an enzyme involved in DNA repair and maintenance of the genome, has been proposed as an early biochemical marker of apoptosis [16, 24] . PARP is cleaved at an Asp residue (Asp-216-Gly-217) with differing efficiencies by several ICE-like proteases, including one termed prICE\ Abbreviations used : ICE, interleukin-1-converting enzyme ; Z-VAD.FMK, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone ; Ac-YVAD-CHO, acetyl Tyr-Val-Ala-Asp aldehyde ; Ac-DEVD-CHO, acetyl Asp-Glu-Val-Asp aldehyde ; PARP, poly(ADP-ribose) polymerase ; TLCK, 1-tosylamido-2-phenylethylchloromethyl ketone ; DTT, dithiothreitol.
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ICE-like protease inhibitor, inhibits apoptosis by preventing the processing of CPP32 to its active form. These results suggest that novel inhibitors of apoptosis can be developed which prevent processing of proforms of ICE-like proteases.
CPP32\Yama\apopain [8, 9, 16] and also by Mch-2 [7] , Mch-3 [17] and TX [25] .
We have recently demonstrated that benzyloxycarbonyl-ValAla-Asp (OMe) fluoromethylketone (Z-VAD.FMK), an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli [26] and Fas antigen-induced apoptosis in Jurkat T-cells [27] . In this study, we demonstrate that Z-VAD.FMK inhibits apoptosis by blocking the activation of proCPP32 into its active form, rather than by preventing the proteolytic action of CPP32 directly.
MATERIALS AND METHODS

Chemicals
Acetyl Asp-Glu-Val-Asp aldehyde (Ac-DEVD-CHO), [$&S]PARP and rabbit polyclonal antibodies to CPP32 were from Merck Frosst, Quebec, Canada. Acetyl Tyr-Val-Ala-Asp aldehyde (Ac-YVAD-CHO) was obtained from Bachem, Switzerland, and Z-VAD.FMK was from Enzyme Systems (Dublin, CA, U.S.A.). 1-Tosylamido-2-phenylethylchloromethyl ketone (TLCK) was purchased from Boehringer-Mannheim U.K. (Lewes, U.K.) and the Fas monoclonal antibody (IgM, clone CH-11) was from TCS Biologicals (Bucks., U.K.).
Cell culture and treatments
The human monocytic tumour cell line, THP.1, was obtained from ECACC (Wiltshire, U.K.) and the leukaemic T-cell line, Jurkat (clone E-6), was obtained from American Type Culture Collection (Rockville, MD, U.S.A.). The cell lines were maintained in RPMI 1640 supplemented with 10 % (v\v) heatinactivated fetal calf serum, 100 units\ml penicillin and 100 µg\ml streptomycin in an atmosphere of 5 % CO # in air at 37 mC. The cells were maintained in logarithmic growth phase by routine passage every 2-3 days. To induce apoptosis in THP.1 cells, 2i10' cells\ml were incubated either alone or in the presence of cycloheximide (25 µM) and TLCK (100 µM) as previously described [26] . In order to assess the possible effects of various ICE-like protease inhibitors, THP.1 cells were also pretreated for 1 h with Z-VAD.FMK (10 µM), Ac-DEVD-CHO (20 µM) and Ac-YVAD-CHO (20 µM) before being exposed to the apoptotic stimulus. To induce apoptosis in Jurkat cells, 2i10' cells\ml were stimulated with 200 ng\ml anti-human Fas as described previously [27] .
Preparation of cell lysates from THP.1 and Jurkat cells
For preparation of lysates from THP.1 cells, cells were incubated as required and then placed on ice, washed twice with ice-cold RPMI 1640 without serum and resuspended in Pipes buffer [50 mM Pipes\KOH (pH 6.5), 2 mM EDTA, 0.1 % (w\v) 3-[(3-cholamideopropyl ) dimethylammonio ] -2 -hydroxy -1 -propanesulphonic acid (CHAPS), 5 mM dithiothreitol (DTT), 20 µg\ml leupeptin, 10 µg\ml pepstatin A, 10 µg\ml aprotinin and 2 mM PMSF) at a concentration of 6i10' cells\10 µl. The cells were frozen and thawed three times in liquid nitrogen and then centrifuged for 30 min at 20 000 g. The supernatant fraction was then centrifuged for a further 30 min at 100 000 g. Lysates from anti-Fas-stimulated Jurkat cells were prepared as previously described [27] . The protein concentration in the supernatant fractions (the lysate) was determined by the Bradford assay (BioRad).
Apoptosis assessed by flow cytometry
Apoptosis was assessed by flow cytometry using Hoechst 33342 as previously described [26, 28] . These cells have been shown to be apoptotic based on a number of criteria including ultrastructure and DNA analysis.
Immunoblot detection of CPP32
THP.1 and Jurkat T-cells were stimulated to undergo apoptosis with apoptotic stimuli and Fas antibodies respectively, and samples of 10' cells were prepared for SDS\PAGE as described [29] . Cellular proteins were resolved on an SDS\12 %-polyacrylamide gel under denaturing conditions and blotted onto nitrocellulose membrane. The blotted proteins were probed with rabbit polyclonal antibodies directed to the p17 subunit of CPP32 followed by chemiluminescence detection [30] .
[
S]PARP cleavage assay
Proteolysis of PARP in cell lysates was measured by the ability of the lysate to cleave [$&S]PARP to a 24 kDa fragment as previously described [8] . Briefly, cell lysates containing 10 µg of protein in 20 µl of Pipes buffer were incubated for 30 min at 37 mC with 5 µl of [$&S]PARP (128 Bq\µl) in the presence or absence of inhibitors as indicated. The reactions were stopped by the addition of Laemmli buffer containing 2-mercaptoethanol and SDS. After boiling for 5 min, the samples were separated on an SDS\10 %-polyacrylamide gel. The gel was fixed for 10 min in a mixture of glacial acetic acid\methanol\water (1 : 2 : 7, by vol.), followed by soaking for 20 min in Enlightning Fluorographic Enhancer (Dupont). The gel was then dried and exposed to autoradiography film.
RESULTS AND DISCUSSION
Ac-DEVD-CHO but not Z-VAD.FMK is a potent inhibitor of PARP protease activity in cell lysates derived from cells undergoing apoptosis
We have previously shown that the induction of apoptosis in THP.1 cells by various stimuli can be enhanced by co-treatment with the trypsin-like protease inhibitor, TLCK [26] . Induction of apoptosis in these cells, assessed by morphological, flow cytometric and biochemical criteria, including the proteolysis of PARP and cleavage of chromatin into large kilobase pair fragments was completely abrogated by the ICE-like protease inhibitor, Z-VAD-FMK [26] . This compound is also a good inhibitor of Fas-induced apoptosis in Jurkat cells [27] and apoptosis induced by various stimuli in thymocytes and hepatocytes [31, 32] , suggesting that its target(s) may be a common mediator of apoptosis in diverse systems.
To investigate the nature of this target, we first examined whether cell lysates derived from THP.1 cells treated with cycloheximide and TLCK contained PARP protease or CPP32-like activity, which appears to be necessary for apoptosis [8, 16] . Cell lysates derived from treated but not control THP.1 cells readily cleaved [$&S]PARP, forming the 24 kDa product [ Figure  1 (top), lanes 1 and 2], as previously described [8] . This PARP protease activity was detected within 30 min of exposure to an apoptotic stimulus (results not shown) and was totally inhibited by low concentrations of Ac-DEVD-CHO [ Figure 1 (top), lanes 3-6], a specific inhibitor of CPP32, which is in good agreement with previous studies [8] . As this compound is not cell permeable [8] , low concentrations had relatively little effect on apoptosis (Table 1) and high concentrations ( 100 µM) were required to FMK (lanes 11-14) . have any noticeable effect on apoptosis (results not shown). Ac-YVAD-CHO (10 µM), a specific cell-permeable ICE inhibitor [5] , had relatively little effect on apoptosis in intact THP.1 cells (Table 1) , nor did it affect the formation of the 24 kDa PARP product [ Figure 1 (top), lanes 7-10]. In marked contrast to its complete inhibition of apoptosis and PARP proteolysis in intact THP.1 cells [26] (Table 1) , Z-VAD.FMK was a poor inhibitor of PARP protease activity in cell lysates [ Figure 1 (top), lanes [11] [12] [13] [14] . Our results suggested that Z-VAD.FMK was not inhibiting CPP32 activity but was blocking apoptosis either by inhibiting the processing of CPP32 or at some earlier stage. To further corroborate these findings, cell lysates, which have been shown to possess apoptotic nuclei promoting activity, were prepared from Fas-treated Jurkat cells [27] . Z-VAD.FMK (10 µM) is a potent inhibitor of Fas-induced apoptosis, assessed by its ability to inhibit both morphological and biochemical changes associated with apoptosis [27] . As illustrated in 
Table 1 Z-VAD.FMK but not Ac-DEVD-CHO or Ac-YVAD-CHO inhibits apoptosis in THP.1 cells
Z-VAD.FMK inhibits activation of PARP protease activity in control cell lysates
Previous studies [8] have shown that the incubation of control THP.1 cell lysates at 37 mC in the presence of DTT for 1 h activates the processing of CPP32 and resulted in detectable PARP protease activity. In good agreement with Nicholson et al. [8] , the 24 kDa PARP product was formed when [$&S]PARP was incubated with control THP.1 cell lysates which were preincubated for 1 h at 37 mC (Figure 2, lane 1) . Using this approach we examined the effect of Z-VAD.FMK on the activation of this PARP protease activity in control THP.1 cell lysates. Activation of this PARP protease activity, which presumably results from processing of CPP32, and possibly other ICE homologues, was prevented by preincubation of control cell lysates with Z-VAD.FMK (Figure 2, lanes 6-8) . Similar concentrations of
Figure 2 Z-VAD.FMK inhibits activation of PARP protease activity in control cell lysates
Lysates (30 µg of protein) from control THP.1 cells were preincubated with DTT for 1 h at 37 mC either alone (lanes 1, 9-11) or with Ac-DEVD-CHO (100 nM) (lane 2), Ac-YVAD-CHO (100 nM-10 µM) (lanes 3-5) or Z-VAD.FMK (100 nM-10 µM) (lanes 6-8). In some reactions (lanes 9-11), inhibitors were added after this initial 1 h preincubation. All lysates were then further incubated at 37 mC with [ 35 S]PARP for 30 min and PARP cleavage was determined as described in Figure 1 (Table 1 ) and in cell lysates (Figures 1 and 2) , do not support a major role for ICE in the induction of apoptosis in THP.1 cells, we cannot totally exclude an involvement of this enzyme. We cannot discern whether the inhibition of PARP proteolysis by Ac-DEVD-CHO ( Figure 2 , lane 2) was due to inhibition of the processing of CPP32 or by direct inhibition of CPP32 PARP protease activity (Figure 2, lane 9) .
Z-VAD.FMK blocks the processing of CPP32
In order to obtain more supporting evidence for the hypothesis that Z-VAD.FMK was inhibiting processing of CPP32, we used polyclonal antibodies directed against the p17 subunit. The CPP32 proenzyme comprises a short N-terminal pro-domain followed by p17 and p12 subunits, with Asp residues present at both the pro-domain\p17 and the p17\p12 junctions [8, 12] . In THP.1 cells exposed to an apoptotic stimulus, CPP32 was cleaved at both these junctions to yield the p17 subunit [ Figure 3 Taken collectively, our present results demonstrate that Z-VAD.FMK inhibits apoptosis not by blocking CPP32 activity as such, but by inhibiting the activation of CPP32, presumably by blocking the process leading to the activation of CPP32 or by interfering directly with the processing of CPP32. Recently it has also been shown that the cytoxic T-lymphocyte-specific serine protease granzyme B cleaves and activates CPP32, leading to PARP cleavage and apoptosis [30] . Thus, in different systems, induction of apoptosis is accompanied by processing and activation of CPP32. This is the first demonstration that inhibition of apoptosis may be accomplished by inhibiting the processing of proforms of ICE-like proteases, such as CPP32, that are activated in apoptosis. Whether Z-VAD.FMK can inhibit the activation of other ICE homologues is not known. Z-VAD.FMK is a Received 1 February 1996 ; accepted 10 February 1996 prototype of a molecule which blocks processing of CPP32, thus explaining its ability to inhibit apoptosis in diverse systems [26, 27, 31, 32] . Our results highlight the possibility of developing novel therapeutic agents based on this action, which would prevent the activation of proforms of members of the ICE family.
